Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

• Status: Completed
• Trial end date: 2018-06-29
• Target enrollment: 0
• Participant gender: Female

Summary

The study is aimed at assessing the clinical follow-up and the outcomes of pregnancies exposed to ella, whether due to failure of the emergency contraception or inadvertent exposure during pregnancy.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: HRA Pharma

Criteria

• Pregnant women, exposed to ella during the menstrual cycle in which the pregnancy started (treatment failure) or at any time during pregnancy (inadvertent exposure during pregnancy)

• Adolescents and/or adults in the USA, depending on the respective State law